Dalts, as a young bloke with Parkinson’s, I’m keen to research...

First 44 Last

Share
Profile

Follow
dsorg

864 Posts.

590

05/03/20

00:07

Post #: 43311622
Share

Originally posted by dalts66 ↑

Fellas,

The effect of medical cannabis on the brain is huge. And I mean this in a positive way, not some dopehead way .

There are several Biotechs looking at this, but all from different angles. The other Oz company I own is looking at it from a Diabetic, Parkinson disease way, another in Europe is looking at it for Dementia. But the fundamentals are the same, its how blood flows around the membranes of the brain. They know it works, they have real world evidence of this. But now testing is taking place to prove it works. And to gain experience with dosing etc. This is awesome news for patients, doctors and shareholders.

But still, as shareholders, we need some patience. Unlike Sleep Apnea, enrolling people onto the TBI trial will take some time. But this is going to be well worth the wait, if all goes well.

The potential of the cannabis plant for medicine is huge. With more clinical testing, it will become mainstream. First movers in this space are an exciting sector at the moment IMO. You just need to filter the nay sayers, and market moves. Do your research, and if the company stays on track with what they announce, relax and await results.

Expand

Dalts, as a young bloke with Parkinson’s, I’m keen to research as much as I can.

This may not be the correct forum and apologies to anyone that doesn’t feel this should be here, but do you mind naming which company is interested in it for PD.

Cheers

IHL Price at posting: 5.3¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

BPM

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

88E

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

Essential Energy conference: Streamlining approvals key to the green energy transition

HVN

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

PAR

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

There are more pages in this discussion • 89 more messages in this thread...

First 44 Last

Add IHL (ASX) to my watchlist

Dalts, as a young bloke with Parkinson’s, I’m keen to research...

Top Stories

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

Essential Energy conference: Streamlining approvals key to the green energy transition

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

Featured News